Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 23, 2024
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery SystemsMarina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, et al.
Drug Delivery and Translational Research|April 8, 2024
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic reviewJulen Rodríguez-Castejón, Marina Beraza-Millor, María Ángeles Solinís, et al.
Pharmaceutics|July 29, 2023
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry DiseaseMarina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, et al.
International Review of Cell and Molecular Biology|September 5, 2022
mRNA delivery technologies: Toward clinical translationItziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, et al.
Nanomaterials (Basel, Switzerland)|February 26, 2020
Nanomedicines to Deliver mRNA: State of the Art and Future PerspectivesItziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, et al.
Nanomaterials (Basel, Switzerland)|July 27, 2022
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry DiseaseJulen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 6, 2025
Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry diseaseJulen Rodríguez-Castejón, Paula Fernández-Muro, Marina Beraza-Millor, et al.
Molecules (Basel, Switzerland)|December 23, 2020
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNAItziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, et al.
Advances in Biochemical Engineering/Biotechnology|September 8, 2019
Gene TherapyAna Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, Julen Rodríguez-Castejón, et al.
Pharmaceutics|June 2, 2021
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease MiceJulen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, et al.
Pageof 2